Concepedia

Rajgokul K. Shanmugam

RK

7

Publications

441

Citations

7

H-Index

2013

Active since

Affiliations

Translational Health Science and Technology Institute(Current)

International Centre for Genetic Engineering and Biotechnology

National Institute of Immunology

Icahn School of Medicine at Mount Sinai

Rajgokul K. Shanmugam is an author at Translational Health Science and Technology Institute specializing in gene expression, virology, and pathogenesis.

ORCID

Top concepts

Publications per year

2013–2020

7

Publications

7

Role of RNA Interference (RNAi) in Dengue Virus Replication and Identification of NS4B as an RNAi Suppressor

Pavan Kumar Kakumani, Sanket S. Ponia, Rajgokul K. Shanmugam et al. · Journal of Virology · 2013 · 194 citations · Full text

, , +18

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice

Viswanathan Ramasamy, Upasana Arora, Rahul Shukla et al. · PLoS neglected tropical diseases · 2018 · 94 citations · Full text

Bispidine-Amino Acid Conjugates Act as a Novel Scaffold for the Design of Antivirals That Block Japanese Encephalitis Virus Replication

V. Haridas, Rajgokul K. Shanmugam, Sandhya Sadanandan et al. · PLoS neglected tropical diseases · 2013 · 42 citations · Full text

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models

Rahul Shukla, Hemalatha Beesetti, Julia A. Brown et al. · EBioMedicine · 2020 · 38 citations · Full text

Dengue NS3, an RNAi suppressor, modulates the human miRNA pathways through its interacting partner

Pavan Kumar Kakumani, Rajgokul K. Shanmugam, Sanket S. Ponia et al. · Biochemical Journal · 2015 · 36 citations

, , +19

Rows per page

1–5 of 7